Dr. Olga Timofeeva Named Director of Molecular Pathology at Temple University Hospital
Olga Timofeeva, PhD, D(ABHI) has been appointed Associate Professor of Pathology and Laboratory Medicine at the Lewis Katz School of Medicine at Temple University (LKSOM), Director of Molecular Pathology and Associate Director of the Immunogenetics Laboratory at Temple University Hospital.
Dr. Timofeeva earned her Doctor of Philosophy in Biochemistry at the Novosibirsk Institute of Bioorganic Chemistry in Novosibirsk, Russia. She completed her postdoctoral fellowship at the National Cancer Institute in Frederick, MD, and a research fellowship at Georgetown University in Washington, DC.
“I look forward to joining Temple and contributing to the Department's missions as well as its excellence through research, teaching, and service,” says Dr. Timofeeva. “I am excited to develop new molecular tests as we move toward an era of precision medicine to choose novel approaches for disease treatment and prevention based on genetic, environmental, and lifestyle factors to benefit patient care. “
Dr. Timofeeva is a board-certified Laboratory Director in Immunogenetics by the American Board of Histocompatibility and Immunogenetics. A major focus of her work is to establish a translational research program for the development of biomarkers for effective management of cancer and transplant patients. Dr. Timofeeva’s research is focused on understanding the utility of cell-free DNA in guiding treatment decisions for cancer patients, for diagnostics and prevention of transplant rejection, and for developing new tests that can be used in clinical practice of oncology and transplantation.
“We are excited to welcome Dr. Timofeeva to our Department,” says Yuri Persidsky, MD, PhD, Professor and Chair of the Department of Pathology and Laboratory Medicine at LKSOM. “She has excellent training in immunogenetics/HLA histotyping which is necessary to expand our transplant programs at Temple. Furthermore, Olga has expertise and research interests in molecular pathology and novel biomarkers for tumor diagnostics and monitoring.”
Prior to joining Temple, Dr. Timofeeva was an Assistant Professor of Oncology at Lombardi Comprehensive Cancer Center at Georgetown University School of Medicine. She is a member of the American Transplant Society, American Society for Histocompatibility and Immunogenetics, American Association for Cancer Research, and American Chemical Society.